Application Nr Approved Date Route Status External Links
NDA020892 None Intravesical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Valstar Is An Anthracycline Topoisomerase Inhibitor Indicated For Intravesical Therapy Of Bcg-Refractory Carcinoma In Situ (Cis) Of The Urinary Bladder In Patients For Whom Immediate Cystectomy Would Be Associated With Unacceptable Morbidity Or Mortality. Valstar Is An Anthracycline Topoisomerase Inhibitor Indicated For Intravesical Therapy Of Bcg-Refractory Carcinoma In Situ (Cis) Of The Urinary Bladder In Patients For Whom Immediate Cystectomy Would Be Associated With Unacceptable Morbidity Or Mortality. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Valrubicin VALRUBICIN ZINC49783788

Comments